Viridian Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Viridian Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 82% to $314,000. Profit margin reached -75711%. Total operating expenses were $254,764,000.
Profit Margin
| 2014 | 4.32M | -7.89M | -182.64% |
|---|---|---|---|
| 2015 | 2.53M | -11.32M | -446.34% |
| 2016 | 3.33M | -12.67M | -379.8% |
| 2017 | 4.00M | -26.51M | -662.3% |
| 2018 | 8.38M | -32.70M | -389.97% |
| 2019 | 4.46M | -42.42M | -950.91% |
| 2020 | 1.05M | -110.98M | -10569.9% |
| 2021 | 2.96M | -79.41M | -2680.26% |
| 2022 | 1.77M | -125.44M | -7079.23% |
| 2023 | 314K | -237.73M | -75711.46% |
VRDN Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 314K | 1.77M | 2.96M | 1.05M | 4.46M | 8.38M | 4.00M | 3.33M | 2.53M | 4.32M |
Cost of revenue | 1.32M | 755K | 620K | 28.30M | 32.79M | 0 | 19.62M | 2.54M | 2.47M | 3.24M |
Gross profit | -1.00M | 1.01M | 2.34M | -27.25M | -28.33M | 8.38M | -15.62M | 789K | 66K | 1.07M |
Operating exp. | ||||||||||
Research and development | 159.76M | 100.89M | 56.88M | 28.30M | 34.79M | 30.42M | 19.62M | 888K | 1.00M | 293K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.66M | 2.55M | 717K |
Total operating expenses | 254.76M | 136.07M | 82.69M | 41.56M | 46.44M | 41.47M | 30.53M | 10.46M | 11.25M | 8.04M |
Operating income | -254.45M | -134.30M | -79.72M | -110.38M | -41.97M | -33.08M | -26.53M | -12.50M | -11.18M | -6.86M |
Other income (expenses), net | 16.71M | 4.43M | 315K | -335K | 106K | 381K | 20K | -2.90M | -141K | -1.02M |
Income before tax | -237.73M | -129.87M | -79.41M | -110.71M | -41.87M | -32.70M | -26.51M | -12.67M | -11.32M | -7.89M |
Income tax expense | 0 | -4.43M | 3K | 269K | 547K | 1.25M | 95K | 95K | 0 | 1.02M |
Net income | -237.73M | -125.44M | -79.41M | -110.98M | -42.42M | -32.70M | -26.51M | -12.67M | -11.32M | -7.89M |
Earnings per share | ||||||||||
Basic EPS | -5.31 | -3.91 | -6.66 | -31.2 | -20.31 | -16.57 | -20.66 | -17.57 | -21 | -52.46 |
Diluted EPS | -5.31 | -3.91 | -6.66 | -31.2 | -20.31 | -16.57 | -20.66 | -17.57 | -21 | -52.46 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |